company background image
A179530 logo

ADBiotech KOSDAQ:A179530 Stock Report

Last Price

₩3.04k

Market Cap

₩27.8b

7D

2.0%

1Y

-20.0%

Updated

25 Mar, 2024

Data

Company Financials

ADBiotech Co., Ltd.

KOSDAQ:A179530 Stock Report

Market Cap: ₩27.8b

A179530 Stock Overview

ADBiotech Co., Ltd. develops and sells antibodies for livestock, fisheries, and humans in South Korea and internationally.

A179530 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

ADBiotech Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for ADBiotech
Historical stock prices
Current Share Price₩3,040.00
52 Week High₩5,680.00
52 Week Low₩2,820.00
Beta0.86
1 Month Change-3.03%
3 Month Change-13.02%
1 Year Change-20.00%
3 Year Change-58.26%
5 Year Changen/a
Change since IPO-40.78%

Recent News & Updates

Recent updates

Shareholder Returns

A179530KR PharmaceuticalsKR Market
7D2.0%4.3%3.1%
1Y-20.0%25.6%13.4%

Return vs Industry: A179530 underperformed the KR Pharmaceuticals industry which returned 25.6% over the past year.

Return vs Market: A179530 underperformed the KR Market which returned 13.4% over the past year.

Price Volatility

Is A179530's price volatile compared to industry and market?
A179530 volatility
A179530 Average Weekly Movement8.0%
Pharmaceuticals Industry Average Movement4.9%
Market Average Movement5.2%
10% most volatile stocks in KR Market12.0%
10% least volatile stocks in KR Market2.4%

Stable Share Price: A179530's share price has been volatile over the past 3 months.

Volatility Over Time: A179530's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200060Hong-Geo Junghttps://adbiotech.com

ADBiotech Co., Ltd. develops and sells antibodies for livestock, fisheries, and humans in South Korea and internationally. The company offers antibiotic, disinfectant, helminthic, over the counter drugs, supplementary feed, and metabolic drugs. It also offers health functional and processed foods.

ADBiotech Co., Ltd. Fundamentals Summary

How do ADBiotech's earnings and revenue compare to its market cap?
A179530 fundamental statistics
Market cap₩27.79b
Earnings (TTM)-₩2.86b
Revenue (TTM)₩10.47b

2.7x

P/S Ratio

-9.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A179530 income statement (TTM)
Revenue₩10.47b
Cost of Revenue₩7.28b
Gross Profit₩3.19b
Other Expenses₩6.05b
Earnings-₩2.86b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-313.27
Gross Margin30.46%
Net Profit Margin-27.34%
Debt/Equity Ratio103.9%

How did A179530 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.